


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:49:09Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405306" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405306</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">World J Urol</journal-id><journal-id journal-id-type="iso-abbrev">World J Urol</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>World Journal of Urology</journal-title></journal-title-group><issn pub-type="ppub">0724-4983</issn><issn pub-type="epub">1433-8726</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405306</article-id><article-id pub-id-type="pmcid-ver">PMC12405306.1</article-id><article-id pub-id-type="pmcaid">12405306</article-id><article-id pub-id-type="pmcaiid">12405306</article-id><article-id pub-id-type="pmid">40892219</article-id><article-id pub-id-type="doi">10.1007/s00345-025-05851-7</article-id><article-id pub-id-type="publisher-id">5851</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Renal arterial pseudoaneurysm after robotic-assisted partial nephrectomy: a single-center analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names initials="YP">Yu-Pin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Chung</surname><given-names initials="HJ">Hsiao-Jen</given-names></name><address><email>hjchung@vghtpe.gov.tw</email></address><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names initials="IS">I-Shen</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lin</surname><given-names initials="TP">Tzu-Ping</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lu</surname><given-names initials="SH">Shing-Hwa</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Huang</surname><given-names initials="EYH">Eric Y. H.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04je98850</institution-id><institution-id institution-id-type="GRID">grid.256105.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 1063</institution-id><institution>Department of Urology, </institution><institution>Fu Jen Catholic University Hospital, Fu Jen Catholic University, </institution></institution-wrap>New Taipei City, Taiwan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03ymy8z76</institution-id><institution-id institution-id-type="GRID">grid.278247.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0604 5314</institution-id><institution>Department of Urology, </institution><institution>Taipei Veterans General Hospital, </institution></institution-wrap>No. 201, Section 2, Shipai Road, Taipei, 11217 Taiwan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00se2k293</institution-id><institution-id institution-id-type="GRID">grid.260539.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2059 7017</institution-id><institution>Department of Urology, College of Medicine and Shu-Tien Urological Research Center, </institution><institution>National Yang Ming Chiao Tung University, </institution></institution-wrap>Taipei, Taiwan </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>43</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">496088</issue-id><elocation-id>526</elocation-id><history><date date-type="received"><day>14</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>21</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="345_2025_Article_5851.pdf"/><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">To determine the incidence of renal artery pseudoaneurysm (RAP) after robotic-assisted partial nephrectomy (RaPN), identify predictive factors, and evaluate endovascular management.</p></sec><sec><title>Methods</title><p id="Par2">The institutional RaPN database was retrospectively reviewed, and data from December 2009 to June 2021 were used. Computed tomography angiography was used to diagnose RAP. Patients who underwent embolization for RAP after RaPN were compared with those without RAP or with RAP managed conservatively. Data on patient demographics, tumor characteristics, and operative outcomes were evaluated, and the predictive factors for RAP after RaPN were determined.</p></sec><sec><title>Results</title><p id="Par3">Of the 544 patients who underwent RaPN, 14 developed RAP after surgery, of which 12 underwent embolization. Most patients experienced gross hematuria and were diagnosed using computed tomography angiography. No patient exhibited recurrent RAP during follow-up. The following was found for patients who underwent embolization for RAP: a higher proportion of men (91.7% vs. 59.4%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.024), higher RENAL nephrometry scores (median: 9.0 vs. 8.0, <italic toggle="yes">p</italic>&#8201;=&#8201;0.02), longer operative times (mean: 349.6 vs. 283.7&#160;min, <italic toggle="yes">p</italic>&#8201;=&#8201;0.046), and longer postoperative hospital stays (median: 6.0 vs. 5.0 days, <italic toggle="yes">p</italic>&#8201;=&#8201;0.031). The N score in the RENAL nephrometry score was significantly higher in the embolization group (<italic toggle="yes">p</italic>&#8201;=&#8201;0.031) than in the nonembolization group. Univariate analysis revealed that RENAL nephrometry scores and total operative time were significant predictors of RAP occurrence.</p></sec><sec><title>Conclusion</title><p id="Par4">The occurrence of RAP was associated with higher RENAL nephrometry scores and longer operative times.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Renal tumor</kwd><kwd>Robotic-assisted partial nephrectomy</kwd><kwd>Renal artery pseudoaneurysm</kwd><kwd>Radius exophytic/Endophytic nearness anterior/Posterior location nephrometry score</kwd><kwd>Preoperative aspects and dimensions used for an anatomical score</kwd></kwd-group><funding-group><award-group><funding-source><institution>National Yang Ming Chiao Tung University</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by National Yang Ming Chiao Tung University</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Renal cell carcinoma is a common urological malignancy worldwide. Epidemiological data from the United States have revealed an increasing incidence of renal cell carcinoma over recent decades [<xref ref-type="bibr" rid="CR1">1</xref>]. With the increased application of imaging modalities, the occurrence of incidentally detected renal cell carcinoma has increased [<xref ref-type="bibr" rid="CR2">2</xref>]. For T1a/T1b renal masses, partial nephrectomy (PN) is the standard treatment [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Although PN is technically more challenging than radical nephrectomy, its oncologic outcomes are similar, and it preserves renal function better than radical nephrectomy [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Advances in minimally invasive techniques and robotic surgical platforms, such as the da Vinci robotic system, provide a three-dimensional field and enable delicate wrist actions and a greater degree of flexibility. Therefore, robotic-assisted PNs (RaPNs) are widely performed. RaPNs decrease blood loss and the duration of hospital stays compared with open PN [<xref ref-type="bibr" rid="CR7">7</xref>]. Nevertheless, a serious life-threatening complication after PN is renal artery pseudoaneurysm (RAP), which, however, has a low incidence [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. RAP usually occurs in the early postoperative period and typically presents with gross hematuria, flank pain, and anemia [<xref ref-type="bibr" rid="CR9">9</xref>]. Emergent transarterial embolization is an effective treatment for hemodynamically unstable RAP patients [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par6">The anatomy of renal masses and complexity of PN can be quantified using two scoring systems: (1) the RENAL nephrometry score, which evaluates tumor radius (R), exophytic/endophytic properties (E), nearness to the collecting system or sinus (N), anterior/posterior location (A), and location relative to polar lines (L) and (2) the preoperative aspects and dimensions used for an anatomical (PADUA) score, which reflects anatomical complexity [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. These tools are used to assess the complexity of planned surgeries for renal tumors and guide surgeons&#8217; management decisions. The risk factors for RAP occurrence have been studied; however, no consensus has been reached on whether the level of renal tumor complexity affects RAP occurrence [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR14">14</xref>&#8211;<xref ref-type="bibr" rid="CR16">16</xref>]. Furthermore, not all patients with RAP after PN require interventions, and some patients can be treated conservatively [<xref ref-type="bibr" rid="CR17">17</xref>]. This study aimed to identify predictive factors specifically associated with RAP cases requiring embolization to improve the understanding and management of clinically significant postoperative pseudoaneurysms after RaPN.</p></sec><sec id="Sec30"><title>Patients and methods</title><sec id="Sec5"><title>Patients</title><p id="Par7">A prospectively maintained database was retrospectively reviewed to identify patients who underwent RaPN for renal tumors between December 2009 and June 2021. This observational study was approved by the Institutional Review Board (TPEVGH-IRB 2023-02-001BC) and conducted per the Declaration of Helsinki and the ICH-GCP guidelines. The requirement for informed consent was waived by the IRB because of the retrospective nature of the study and the anonymization of patient data.</p></sec><sec id="Sec6"><title>Surgical procedures</title><p id="Par8">RaPN was performed using a transperitoneal or retroperitoneal robotic-assisted technique, with vascular control achieved per surgeon&#8217;s preference. Tumor excision was consistently performed with a margin of normal renal parenchyma to ensure oncologic safety, and pure enucleation was not routinely performed. Renorrhaphy was performed after tumor excision in a stepwise manner. Transected vessels and collecting system defects at the resection site base were closed using running 3&#8211;0&#160;V-Loc sutures. Next, vascular clamps were released to restore blood flow and ensure adequate hemostasis. Hemostatic agents, such as Floseal, were applied over the defect, and a surgical bolster was placed. Finally, the edges of the renal parenchyma were approximated using 1&#8722;0 Polysorb sutures (Covidien), an absorbable synthetic copolymer made of glycolide and lactide (Lactomer 9&#8722;1).</p></sec><sec id="Sec7"><title>RAP diagnosis and management</title><p id="Par9">RAP was diagnosed via computed tomography (CT) angiography for patients with clinical signs of RAP, such as hematuria, flank pain, and anemia, after RaPN or during the follow-up protocol. Decisions regarding whether patients underwent embolization for RAP were based on the patients&#8217; clinical conditions. Transarterial angioembolization was performed according to the interventional radiology protocol.</p><p id="Par10">Patients were routinely followed up in the outpatient clinic 10&#8211;14 days after discharge to review pathology and assess postoperative recovery. Follow-up imaging was typically recommended for asymptomatic patients every 3 months during the 1st postoperative year, with ultrasound and CT alternated based on physician preference and clinical context. CT renal angiography was not routinely performed at the 1- or 3-month follow-up unless prompted by symptoms suggesting RAP, such as gross hematuria, flank pain, and unexplained anemia. Considering this was a retrospective study, the actual follow-up intervals varied between patients. Follow-up duration was defined as the time between surgery and the last available outpatient visit or imaging at our institution.</p></sec><sec id="Sec8"><title>Data collection</title><p id="Par11">Patients were categorized into two groups for evaluating the factors associated with clinically significant RAP requiring intervention: those who underwent transarterial embolization for RAP (the embolization group) and those who did not, including patients without RAP and those managed conservatively (the nonembolization group). Patient demographics and baseline characteristics included the following: gender, body mass index, American Society of Anesthesiologists physical status classification, use of antiplatelet or anticoagulant, tumor size, tumor RENAL nephrometry score [<xref ref-type="bibr" rid="CR12">12</xref>], tumor PADUA classification [<xref ref-type="bibr" rid="CR13">13</xref>], operative time, estimated blood loss, ischemia time, and intraoperative complications (according to Clavien&#8211;Dindo classification). The tumor size was defined as the maximal diameter (in mm) determined by the preoperative CT scan. The pathological diagnosis was made according to the 2004 World Health Organization classification.</p></sec><sec id="Sec2"><title>Statistical analysis</title><p id="Par12">Descriptive statistics of the categorical variables are reported as means and standard deviations or medians and interquartile ranges. Continuous variables were compared using the Mann&#8211;Whitney U test, and categorical variables were compared using the &#967;<sup>2</sup> test. Univariate logistic regression models were used to determine the variables that independently correlated with RAP occurrence. Statistical analyses were performed using SPSS for Windows version 22 (IBM, Armonk, NY, USA). A two-sided <italic toggle="yes">p</italic> value of &lt;&#8201;0.05 was considered statistically significant.</p></sec></sec><sec id="Sec3"><title>Results</title><p id="Par13">A total of 544 patients who underwent RaPN for renal tumors were included in this study. Of these, 14 (2.6%) developed RAP, 12 (2.2%) underwent embolization, and 2 were managed conservatively. Of 12 patients who underwent embolization, 10 and 2 received transperitoneal RaPN and retroperitoneal RaPN, respectively. The median time to RAP presentation was 9.5 days. Two patients had a history of antiplatelet or anticoagulant use; both had these medications withheld before surgery.</p><p id="Par14">Of two patients managed conservatively, one had a 6-mm RAP detected during hospitalization for flank pain. Follow-up CT at 6 months showed resolution of the lesion, with no recurrence observed on annual imaging for up to 4 years. The other patient had a 9-mm RAP with perirenal hematoma detected during hospitalization. CT at 6 months showed no residual RAP, with no recurrence observed on follow-up imaging over 2 years.</p><p id="Par15">The embolization group had a significantly higher proportion of male patients (91.7% vs. 59.4%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.024) and RENAL nephrometry scores (median 9.0 vs. 8.0, <italic toggle="yes">p</italic>&#8201;=&#8201;0.02) than the nonembolization group, with only the N component being significantly higher in the embolization group. No significant differences in PADUA scores were observed between the groups (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>).</p><p id="Par16">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Patient and tumor characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variables</th><th align="left" colspan="1" rowspan="1">Embolization<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;12)</th><th align="left" colspan="1" rowspan="1">No embolization<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;532)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age (years), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">58.9&#8201;&#177;&#8201;9.0</td><td align="left" colspan="1" rowspan="1">57.1&#8201;&#177;&#8201;13.2</td><td char="." align="char" colspan="1" rowspan="1">0.654</td></tr><tr><td align="left" colspan="1" rowspan="1">Male (%)</td><td align="left" colspan="1" rowspan="1">11 (91.7%)</td><td align="left" colspan="1" rowspan="1">316 (59.4%)</td><td char="." align="char" colspan="1" rowspan="1">0.024</td></tr><tr><td align="left" colspan="1" rowspan="1">BMI, median (IQR)</td><td align="left" colspan="1" rowspan="1">26.4 (25.1&#8211;28.3)</td><td align="left" colspan="1" rowspan="1">25.2 (22.7&#8211;27.8)</td><td char="." align="char" colspan="1" rowspan="1">0.154</td></tr><tr><td align="left" colspan="1" rowspan="1">ASA, median (IQR)</td><td align="left" colspan="1" rowspan="1">2.0 (2.0&#8211;2.0)</td><td align="left" colspan="1" rowspan="1">2.0 (2.0&#8211;2.0)</td><td char="." align="char" colspan="1" rowspan="1">0.770</td></tr><tr><td align="left" colspan="1" rowspan="1">Right side (%)</td><td align="left" colspan="1" rowspan="1">8 (66.7%)</td><td align="left" colspan="1" rowspan="1">286 (53.8%)</td><td char="." align="char" colspan="1" rowspan="1">0.375</td></tr><tr><td align="left" colspan="1" rowspan="1">Tumor size on CT (mm), median (IQR)</td><td align="left" colspan="1" rowspan="1">39.0 (33.5&#8211;43.0)</td><td align="left" colspan="1" rowspan="1">36.0 (27.0&#8211;50.0)</td><td char="." align="char" colspan="1" rowspan="1">0.739</td></tr><tr><td align="left" colspan="1" rowspan="1">RENAL nephrometry score, median (IQR)</td><td align="left" colspan="1" rowspan="1">9.0 (8.0&#8211;9.0)</td><td align="left" colspan="1" rowspan="1">8.0 (7.0&#8211;9.0)</td><td char="." align="char" colspan="1" rowspan="1">0.02</td></tr><tr><td align="left" colspan="1" rowspan="1">Radius</td><td align="left" colspan="1" rowspan="1">1.5 (1.0&#8211;2.0)</td><td align="left" colspan="1" rowspan="1">1.0 (1.0&#8211;2.0)</td><td char="." align="char" colspan="1" rowspan="1">0.606</td></tr><tr><td align="left" colspan="1" rowspan="1">Exophytic/endophytic</td><td align="left" colspan="1" rowspan="1">2.0 (1.0&#8211;2.0)</td><td align="left" colspan="1" rowspan="1">2.0 (1.0&#8211;2.0)</td><td char="." align="char" colspan="1" rowspan="1">0.2</td></tr><tr><td align="left" colspan="1" rowspan="1">Nearness to collecting system or sinus</td><td align="left" colspan="1" rowspan="1">3.0 (3.0&#8211;3.0)</td><td align="left" colspan="1" rowspan="1">3.0 (2.0&#8211;3.0)</td><td char="." align="char" colspan="1" rowspan="1">0.031</td></tr><tr><td align="left" colspan="1" rowspan="1">Anterior (%)</td><td align="left" colspan="1" rowspan="1">7 (58.3%)</td><td align="left" colspan="1" rowspan="1">286(53.9%)</td><td char="." align="char" colspan="1" rowspan="1">0.446</td></tr><tr><td align="left" colspan="1" rowspan="1">Location relative to polar lines</td><td align="left" colspan="1" rowspan="1">2.5 (2.0&#8211;3.0)</td><td align="left" colspan="1" rowspan="1">2.0 (1.0&#8211;3.0)</td><td char="." align="char" colspan="1" rowspan="1">0.227</td></tr><tr><td align="left" colspan="1" rowspan="1">PADUA score, median (IQR)</td><td align="left" colspan="1" rowspan="1">10.0 (9.0&#8211;11.0)</td><td align="left" colspan="1" rowspan="1">9.0 (8.0&#8211;10.0)</td><td char="." align="char" colspan="1" rowspan="1">0.073</td></tr><tr><td align="left" colspan="1" rowspan="1">Polar location</td><td align="left" colspan="1" rowspan="1">2.0 (1.0&#8211;2.0)</td><td align="left" colspan="1" rowspan="1">2.0 (1.0&#8211;2.0)</td><td char="." align="char" colspan="1" rowspan="1">0.355</td></tr><tr><td align="left" colspan="1" rowspan="1">Exophytic</td><td align="left" colspan="1" rowspan="1">2.0 (1.0&#8211;2.0)</td><td align="left" colspan="1" rowspan="1">2.0 (1.0&#8211;2.0)</td><td char="." align="char" colspan="1" rowspan="1">0.192</td></tr><tr><td align="left" colspan="1" rowspan="1">Renal rim</td><td align="left" colspan="1" rowspan="1">1.0 (1.0&#8211;2.0)</td><td align="left" colspan="1" rowspan="1">1.0 (1.0&#8211;2.0)</td><td char="." align="char" colspan="1" rowspan="1">0.989</td></tr><tr><td align="left" colspan="1" rowspan="1">Renal sinus invasion</td><td align="left" colspan="1" rowspan="1">2.0 (2.0&#8211;2.0)</td><td align="left" colspan="1" rowspan="1">1.0 (1.0&#8211;2.0)</td><td char="." align="char" colspan="1" rowspan="1">0.075</td></tr><tr><td align="left" colspan="1" rowspan="1">Collecting system invasion</td><td align="left" colspan="1" rowspan="1">2.0 (1.0&#8211;2.0)</td><td align="left" colspan="1" rowspan="1">1.0 (1.0&#8211;2.0)</td><td char="." align="char" colspan="1" rowspan="1">0.168</td></tr><tr><td align="left" colspan="1" rowspan="1">Tumor size</td><td align="left" colspan="1" rowspan="1">1.5 (1.0&#8211;2.0)</td><td align="left" colspan="1" rowspan="1">1.0 (1.0&#8211;2.0)</td><td char="." align="char" colspan="1" rowspan="1">0.771</td></tr></tbody></table><table-wrap-foot><p><italic toggle="yes">ASA</italic> American Society of Anesthesiologists physical status classification, <italic toggle="yes">BMI</italic> body mass index, <italic toggle="yes">CT</italic> computed tomography, <italic toggle="yes">IQR</italic> interquartile range, <italic toggle="yes">PADUA</italic> preoperative aspects and dimensions used for an anatomical, <italic toggle="yes">RENAL</italic> radius exophytic/endophytic nearness anterior/posterior location</p></table-wrap-foot></table-wrap>
</p><p id="Par17">The operative time and postoperative hospital stay were significantly longer in the embolization group than in the nonembolization group (349.6 vs. 283.7&#160;min, <italic toggle="yes">p</italic>&#8201;=&#8201;0.046 and 6.0 vs. 5.0 days, <italic toggle="yes">p</italic>&#8201;=&#8201;0.031, respectively). No significant differences in other surgical parameters, including warm ischemia time, estimated blood loss, and intraoperative blood transfusion rates, were observed between the two groups (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).</p><p id="Par18">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Surgical outcomes and functional follow-up data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variables</th><th align="left" colspan="1" rowspan="1">Embolization<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;12)</th><th align="left" colspan="1" rowspan="1">No embolization<break/>(<italic toggle="yes">n</italic>&#8201;=&#8201;532)</th><th align="left" colspan="1" rowspan="1"><italic toggle="yes">p</italic> value</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Operative time (min), mean&#8201;&#177;&#8201;SD</td><td align="left" colspan="1" rowspan="1">349.6&#8201;&#177;&#8201;113.1</td><td align="left" colspan="1" rowspan="1">283.7&#8201;&#177;&#8201;91.4</td><td align="left" colspan="1" rowspan="1">0.046</td></tr><tr><td align="left" colspan="1" rowspan="1">Warm ischemia time (min), median (IQR)</td><td align="left" colspan="1" rowspan="1">29.5 (22.2&#8211;34.3)</td><td align="left" colspan="1" rowspan="1">23.0 (16.0&#8211;32.0)</td><td align="left" colspan="1" rowspan="1">0.109</td></tr><tr><td align="left" colspan="1" rowspan="1">EBL (ml), median (IQR)</td><td align="left" colspan="1" rowspan="1">287.5 (200.0&#8211;462.5)</td><td align="left" colspan="1" rowspan="1">180 (100.0&#8211;350.0)</td><td align="left" colspan="1" rowspan="1">0.077</td></tr><tr><td align="left" colspan="1" rowspan="1">Intraoperative transfusion (%)</td><td align="left" colspan="1" rowspan="1">2 (13.3%)</td><td align="left" colspan="1" rowspan="1">46 (8.6%)</td><td align="left" colspan="1" rowspan="1">0.679</td></tr><tr><td align="left" colspan="1" rowspan="1">Postoperative stays (days), median (IQR)</td><td align="left" colspan="1" rowspan="1">6.0(5.0&#8211;7.0)</td><td align="left" colspan="1" rowspan="1">5.0 (5.0&#8211;6.0)</td><td align="left" colspan="1" rowspan="1">0.031</td></tr><tr><td align="left" colspan="1" rowspan="1">Time to RAP (days), median (IQR)</td><td align="left" colspan="1" rowspan="1">9.5 (5.0&#8211;13.5)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Follow-up period (months), median (IQR)</td><td align="left" colspan="1" rowspan="1">23.0 (20.5&#8211;52.5)</td><td align="left" colspan="1" rowspan="1">26.0 (9.0&#8211;58.0)</td><td align="left" colspan="1" rowspan="1">0.565</td></tr></tbody></table><table-wrap-foot><p>
<italic toggle="yes">EBL</italic> estimated blood loss, <italic toggle="yes">IQR</italic> interquartile range, <italic toggle="yes">RAP</italic> renal artery pseudoaneurysm</p></table-wrap-foot></table-wrap>
</p><table-wrap id="Tab3" position="float" orientation="portrait"><label>Table&#160;3</label><caption><p>Patient, tumor, and surgery characteristics and clinical presentations in individual patients diagnosed with renal artery pseudoaneurysm (RAP)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Patient no.</th><th align="left" colspan="2" rowspan="1">Treatment</th><th align="left" colspan="1" rowspan="1">Gender</th><th align="left" colspan="1" rowspan="1">Age</th><th align="left" colspan="1" rowspan="1">Tumor size (cm)</th><th align="left" colspan="1" rowspan="1">Warm ischemia time (min)</th><th align="left" colspan="1" rowspan="1">Tumor pathology</th><th align="left" colspan="1" rowspan="1">Clinical presentation</th><th align="left" colspan="1" rowspan="1">Postoperative days to symptoms</th><th align="left" colspan="1" rowspan="1">Operation</th><th align="left" colspan="1" rowspan="1">RENAL nephrometry score</th><th align="left" colspan="1" rowspan="1">PADUA score</th><th align="left" colspan="1" rowspan="1">Antiplatelet or anticoagulant use</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="2" rowspan="1">Embolization</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">48</td><td align="left" colspan="1" rowspan="1">36</td><td align="left" colspan="1" rowspan="1">22.3</td><td align="left" colspan="1" rowspan="1">AML</td><td align="left" colspan="1" rowspan="1">Flank pain</td><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">Transperitoneal</td><td align="left" colspan="1" rowspan="1">113a1</td><td align="left" colspan="1" rowspan="1">111,111</td><td align="left" colspan="1" rowspan="1">No</td></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="2" rowspan="1">Embolization</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">63</td><td align="left" colspan="1" rowspan="1">37</td><td align="left" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">Clear cell</td><td align="left" colspan="1" rowspan="1">Flank pain, gross hematuria</td><td align="left" colspan="1" rowspan="1">9</td><td align="left" colspan="1" rowspan="1">Transperitoneal</td><td align="left" colspan="1" rowspan="1">123a3</td><td align="left" colspan="1" rowspan="1">322,221</td><td align="left" colspan="1" rowspan="1">Yes</td></tr><tr><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="2" rowspan="1">Embolization</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">61</td><td align="left" colspan="1" rowspan="1">34</td><td align="left" colspan="1" rowspan="1">23</td><td align="left" colspan="1" rowspan="1">Chromophobe</td><td align="left" colspan="1" rowspan="1">Gross hematuria</td><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="1" rowspan="1">Transperitoneal</td><td align="left" colspan="1" rowspan="1">123p3</td><td align="left" colspan="1" rowspan="1">222,221</td><td align="left" colspan="1" rowspan="1">No</td></tr><tr><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="2" rowspan="1">Embolization</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">65</td><td align="left" colspan="1" rowspan="1">43</td><td align="left" colspan="1" rowspan="1">53</td><td align="left" colspan="1" rowspan="1">Clear cell</td><td align="left" colspan="1" rowspan="1">Gross hematuria</td><td align="left" colspan="1" rowspan="1">31</td><td align="left" colspan="1" rowspan="1">Transperitoneal</td><td align="left" colspan="1" rowspan="1">223a1</td><td align="left" colspan="1" rowspan="1">121,212</td><td align="left" colspan="1" rowspan="1">No</td></tr><tr><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="2" rowspan="1">Embolization</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">55</td><td align="left" colspan="1" rowspan="1">47</td><td align="left" colspan="1" rowspan="1">31</td><td align="left" colspan="1" rowspan="1">Clear cell</td><td align="left" colspan="1" rowspan="1">Gross hematuria, urinary retention</td><td align="left" colspan="1" rowspan="1">41</td><td align="left" colspan="1" rowspan="1">Transperitoneal</td><td align="left" colspan="1" rowspan="1">223p3</td><td align="left" colspan="1" rowspan="1">221,222</td><td align="left" colspan="1" rowspan="1">No</td></tr><tr><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="2" rowspan="1">Embolization</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">52</td><td align="left" colspan="1" rowspan="1">41</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">Chromophobe</td><td align="left" colspan="1" rowspan="1">Gross hematuria, urinary retention</td><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">Transperitoneal</td><td align="left" colspan="1" rowspan="1">223p2</td><td align="left" colspan="1" rowspan="1">121,212</td><td align="left" colspan="1" rowspan="1">Yes</td></tr><tr><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="2" rowspan="1">Embolization</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">56</td><td align="left" colspan="1" rowspan="1">32</td><td align="left" colspan="1" rowspan="1">25</td><td align="left" colspan="1" rowspan="1">Clear cell</td><td align="left" colspan="1" rowspan="1">Flank pain, gross hematuria</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">Transperitoneal</td><td align="left" colspan="1" rowspan="1">123a3</td><td align="left" colspan="1" rowspan="1">221,221</td><td align="left" colspan="1" rowspan="1">No</td></tr><tr><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="2" rowspan="1">Embolization</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">71</td><td align="left" colspan="1" rowspan="1">42</td><td align="left" colspan="1" rowspan="1">28.9</td><td align="left" colspan="1" rowspan="1">Oncocytoma</td><td align="left" colspan="1" rowspan="1">Gross hematuria</td><td align="left" colspan="1" rowspan="1">13</td><td align="left" colspan="1" rowspan="1">Transperitoneal</td><td align="left" colspan="1" rowspan="1">223a3</td><td align="left" colspan="1" rowspan="1">222,222</td><td align="left" colspan="1" rowspan="1">No</td></tr><tr><td align="left" colspan="1" rowspan="1">9</td><td align="left" colspan="2" rowspan="1">Embolization</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">58</td><td align="left" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">22</td><td align="left" colspan="1" rowspan="1">Clear cell</td><td align="left" colspan="1" rowspan="1">Flank pain, gross hematuria</td><td align="left" colspan="1" rowspan="1">9</td><td align="left" colspan="1" rowspan="1">Retroperitoneal</td><td align="left" colspan="1" rowspan="1">133p2</td><td align="left" colspan="1" rowspan="1">231,211</td><td align="left" colspan="1" rowspan="1">No</td></tr><tr><td align="left" colspan="1" rowspan="1">10</td><td align="left" colspan="2" rowspan="1">Embolization</td><td align="left" colspan="1" rowspan="1">F</td><td align="left" colspan="1" rowspan="1">73</td><td align="left" colspan="1" rowspan="1">64</td><td align="left" colspan="1" rowspan="1">43</td><td align="left" colspan="1" rowspan="1">AML</td><td align="left" colspan="1" rowspan="1">Flank pain</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">Transperitoneal</td><td align="left" colspan="1" rowspan="1">313p2</td><td align="left" colspan="1" rowspan="1">212,112</td><td align="left" colspan="1" rowspan="1">No</td></tr><tr><td align="left" colspan="1" rowspan="1">11</td><td align="left" colspan="2" rowspan="1">Embolization</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">42</td><td align="left" colspan="1" rowspan="1">43</td><td align="left" colspan="1" rowspan="1">41</td><td align="left" colspan="1" rowspan="1">Clear cell</td><td align="left" colspan="1" rowspan="1">Flank pain</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">Transperitoneal</td><td align="left" colspan="1" rowspan="1">223a2</td><td align="left" colspan="1" rowspan="1">221,222</td><td align="left" colspan="1" rowspan="1">No</td></tr><tr><td align="left" colspan="1" rowspan="1">12</td><td align="left" colspan="2" rowspan="1">Embolization</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">63</td><td align="left" colspan="1" rowspan="1">32</td><td align="left" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">Clear cell</td><td align="left" colspan="1" rowspan="1">Gross hematuria</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">Retroperitoneal</td><td align="left" colspan="1" rowspan="1">113a3</td><td align="left" colspan="1" rowspan="1">211,121</td><td align="left" colspan="1" rowspan="1">No</td></tr><tr><td align="left" colspan="1" rowspan="1">13</td><td align="left" colspan="2" rowspan="1">Conservative treatment</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">40</td><td align="left" colspan="1" rowspan="1">25</td><td align="left" colspan="1" rowspan="1">14</td><td align="left" colspan="1" rowspan="1">Clear cell</td><td align="left" colspan="1" rowspan="1">Flank pain</td><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">Transperitoneal</td><td align="left" colspan="1" rowspan="1">133a3</td><td align="left" colspan="1" rowspan="1">231,111</td><td align="left" colspan="1" rowspan="1">No</td></tr><tr><td align="left" colspan="1" rowspan="1">14</td><td align="left" colspan="2" rowspan="1">Conservative treatment</td><td align="left" colspan="1" rowspan="1">M</td><td align="left" colspan="1" rowspan="1">47</td><td align="left" colspan="1" rowspan="1">46</td><td align="left" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">Leiomyoma</td><td align="left" colspan="1" rowspan="1">Flank pain</td><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">Retroperitoneal</td><td align="left" colspan="1" rowspan="1">213p1</td><td align="left" colspan="1" rowspan="1">112,112</td><td align="left" colspan="1" rowspan="1">No</td></tr></tbody></table><table-wrap-foot><p>Treatment refers to the clinical management approach for RAP. &#8220;Embolization&#8221; indicates patients who underwent angiographic embolization. &#8220;Conservative treatment&#8221; indicates patients managed without intervention</p><p><italic toggle="yes">AML</italic> angiomyolipoma, <italic toggle="yes">PADUA</italic> preoperative aspects and dimensions used for an anatomical, <italic toggle="yes">RENAL</italic> radius exophytic/endophytic nearness anterior/posterior location</p></table-wrap-foot></table-wrap><p id="Par19">Univariate analysis revealed that higher RENAL nephrometry scores and longer total operative time significantly predicted RAP occurrence and the need for embolization.</p><p id="Par20">Table&#160;<xref rid="Tab3" ref-type="table">3</xref> shows the demographic and tumor characteristics and clinical presentations of the 14 patients diagnosed with RAP (12 who underwent embolization and 2 who were managed conservatively). Most patients presented with gross hematuria and were diagnosed using contrast-enhanced CT. All embolization procedures successfully controlled bleeding, and none of the patients required nephrectomy or experienced rebleeding during follow-up. The median follow-up duration was 23 months, and no patients were lost to follow-up.</p></sec><sec id="Sec4"><title>Discussion</title><p id="Par21">PN is beneficial for pT1a and even pT1b lesions owing to oncological control and preservation of renal parenchyma [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Minimally invasive technology is advancing quickly, and RaPN is a favorable treatment option for nephron-sparing surgery. Nevertheless, RaPN is challenging and may lead to complications, including RAP. The incidence of RAP after minimally invasive RaPN is higher than that after the open approach to PN [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. Risk factors for RAP were identified in several studies [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. However, few studies have focused on pseudoaneurysm in patients undergoing RaPN [<xref ref-type="bibr" rid="CR17">17</xref>]. The present study demonstrated that the occurrence of RAP after RaPN is low (2.6%) and that higher RENAL nephrometry scores and longer total operative times are predictors for RAP occurrence.</p><p id="Par22">Tumor complexity may influence RaPN outcomes and RAP occurrence; however, the results of previous studies are controversial. In a study by Omae et al. [<xref ref-type="bibr" rid="CR16">16</xref>], CT angiography was performed 3&#8211;4 days after minimally invasive PN in 101 patients, and univariate analysis revealed that RAP was associated with large tumor size, a higher N component score, renal sinus exposure, and opening of the collecting system. Our study showed that the RENAL nephrometry score N component was higher in the embolization group than in the nonembolization group; however, univariate analysis revealed that only higher RENAL nephrometry scores were associated with RAP occurrence. This discrepancy may be due to the unbalanced patient numbers in the two groups. Conversely, the renal sinus invasion component of the PADUA score did not differ between the two groups, which is not in agreement with the findings of Omae et al. Excision and suturing of the renal parenchyma and sinus may lacerate the arterioles, resulting in RAP; however, this was not directly reflected in the occurrence of RAP.</p><p id="Par23">Herein, the incidence of RAP after RaPN was 2.6%. A systematic review by Jain et al. [<xref ref-type="bibr" rid="CR9">9</xref>] reported an incidence of 1.00% for open PN and 1.96% for minimally invasive approaches, including laparoscopic and robotic PN, indicating a significant difference between the two techniques (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). In Chavali et al.&#8217;s [<xref ref-type="bibr" rid="CR8">8</xref>] study, the incidence rate of RAP was 1.4% in 1,417 patients who underwent PN, and univariate analysis revealed that longer operative time and cold ischemia time were significant risk factors for RAP. In our study, high RENAL nephrometry scores and long total operative times were associated with RAP occurrence. The differences between these two studies is potentially because of different study populations: Chavali et al. analyzed patients who underwent minimally invasive or open PNs, whereas our study only included patients who underwent RaPN. Furthermore, RaPN in patients with higher RENAL nephrometry scores is more challenging. Besides, RENAL nephrometry scores were higher in the embolization group in our study than those in Chavali et al.&#8217;s (9 vs. 8) study. This may explain why high RENAL nephrometry scores were a risk factor only in our study.</p><p id="Par24">Tumor location may influence the occurrence of complications after PN. Nadu et al. [<xref ref-type="bibr" rid="CR20">20</xref>] defined central tumors as enhancing lesions coming into contact with or invading the collecting system or renal sinus. In their study of 212 patients who underwent laparoscopic PN, including 53 patients with central tumors, Nadu et al. found that RAP was significantly more common in patients with central tumors [<xref ref-type="bibr" rid="CR20">20</xref>]. Additionally, the proximity of the tumor to the collecting system was associated with overall surgical complication rates in a study by Sempels et al. [<xref ref-type="bibr" rid="CR22">22</xref>], which is consistent with our study.</p><p id="Par25">Our results demonstrated that higher RENAL nephrometry scores, but not PADUA scores, were associated with RAP occurrence. This difference may be due to the differently classified tumor complexities of the groups. For the embolization group, RENAL nephrometry scores indicated intermediate complexity, whereas PADUA scores indicated high complexity. Furthermore, the N component differs between the RENAL nephrometry and PADUA score systems. The N component includes the collecting system and renal sinus involvement in the RENAL nephrometry scoring system, whereas the collecting system and renal sinus involvement are considered separately in the PADUA scoring system. Overall, nephrometry scores are useful because they provide surgeons with preoperative information. However, the occurrence of complications depends not only on nephrometry scores but also on the surgeon&#8217;s experience, surgical plan, and patient comorbidities.</p><p id="Par26">The present study has several strengths. All patients analyzed in this study underwent RaPN. Thus, the occurrence of RAP on the robot platform was revealed. Our study also analyzed RENAL nephrometry scores, PADUA scores, and their nephrometry components simultaneously, providing a more comprehensive analysis of RAP risk factors. Nevertheless, there are several limitations to the present study. First, this was a retrospective study, which may have been influenced by confounders. Second, all patients were analyzed from a single institute, which may not reflect interinstitute and general population differences. Third, not all operations were performed by a single surgeon, and different surgeons may have different experience levels and techniques. Additionally, the long study period may have introduced variability in surgical techniques and perioperative care owing to refinements and improvements over time. Finally, the low occurrence of RAP and the unbalanced distribution between groups, combined with the retrospective nature of the study and the absence of an a priori sample size calculation, may have limited the statistical power of certain comparisons.</p><p id="Par27">In conclusion, the incidence of RAP after RaPN was 2.6% at our institute. The occurrence of RAP was associated with higher RENAL nephrometry scores and longer total operative times. Hence, for patients with higher RENAL nephrometry scores and longer operative times, postoperative vigilance for RAP occurrence is required.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>Yu-Pin Huang contributed to data collection and management, data analysis, manuscript writing, and manuscript reviewing. Hsiao-Jen Chung contributed to project development, data collection and management, data analysis, manuscript editing, and manuscript reviewing. Data collection was performed by I-Shen Huang, Tzu-Ping Lin, Eric Y.H. Huang, and Shing-Hwa Lu.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by National Yang Ming Chiao Tung University. This study was funded by Cheng-Hsin General Hospital and Taipei Veteran General Hospital (V109C-188).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par28">The authors declare no competing interests.</p></notes><notes id="FPar2"><title>Ethical approval</title><p id="Par29">This observational study was approved by the Institutional Review Board (TPEVGH-IRB 2023-02-001BC) and conducted per the Declaration of Helsinki and the ICH-GCP guidelines.</p></notes><notes id="FPar3"><title>Informed consent</title><p id="Par30">The requirement for informed consent was waived by the IRB due to the retrospective nature of the study and the anonymization of patient data.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siegel</surname><given-names>RL</given-names></name><name name-style="western"><surname>Miller</surname><given-names>KD</given-names></name><name name-style="western"><surname>Fuchs</surname><given-names>HE</given-names></name><name name-style="western"><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Cancer statistics, 2022</article-title><source>CA Cancer J Clin</source><year>2022</year><volume>72</volume><fpage>7</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.3322/caac.21708</pub-id><pub-id pub-id-type="pmid">35020204</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7&#8211;33. 10.3322/caac.21708<pub-id pub-id-type="pmid">35020204</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3322/caac.21708</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hock</surname><given-names>LM</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>J</given-names></name><name name-style="western"><surname>Balaji</surname><given-names>KC</given-names></name></person-group><article-title>Increasing incidence of all stages of kidney cancer in the last 2 decades in the united states: an analysis of surveillance, epidemiology and end results program data</article-title><source>J Urol</source><year>2002</year><volume>167</volume><fpage>57</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/S0022-5347(05)65382-7</pub-id><pub-id pub-id-type="pmid">11743275</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Hock LM, Lynch J, Balaji KC (2002) Increasing incidence of all stages of kidney cancer in the last 2 decades in the united states: an analysis of surveillance, epidemiology and end results program data. J Urol 167:57&#8211;60. 10.1016/S0022-5347(05)65382-7<pub-id pub-id-type="pmid">11743275</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>WC</given-names></name><name name-style="western"><surname>Atoria</surname><given-names>CL</given-names></name><name name-style="western"><surname>Bjurlin</surname><given-names>M</given-names></name></person-group><article-title>Management of small kidney cancers in the new millennium: contemporary trends and outcomes in a population-based cohort</article-title><source>JAMA Surg</source><year>2015</year><volume>150</volume><fpage>664</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1001/jamasurg.2015.0294</pub-id><pub-id pub-id-type="pmid">26017316</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Huang WC, Atoria CL, Bjurlin M (2015) Management of small kidney cancers in the new millennium: contemporary trends and outcomes in a population-based cohort. JAMA Surg 150:664&#8211;672. 10.1001/jamasurg.2015.0294<pub-id pub-id-type="pmid">26017316</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamasurg.2015.0294</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>SG</given-names></name><name name-style="western"><surname>Penson</surname><given-names>DF</given-names></name><name name-style="western"><surname>Pabla</surname><given-names>B</given-names></name><name name-style="western"><surname>Clark</surname><given-names>PE</given-names></name><name name-style="western"><surname>Cookson</surname><given-names>MS</given-names></name><name name-style="western"><surname>Chang</surname><given-names>SS</given-names></name><name name-style="western"><surname>Herrell</surname><given-names>SD</given-names></name><name name-style="western"><surname>Smith</surname><given-names>JA</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Barocas</surname><given-names>DA</given-names></name></person-group><article-title>National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats</article-title><source>J Urol</source><year>2012</year><volume>187</volume><fpage>816</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2011.10.173</pub-id><pub-id pub-id-type="pmid">22248514</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Patel SG, Penson DF, Pabla B, Clark PE, Cookson MS, Chang SS, Herrell SD, Smith JA Jr, Barocas DA (2012) National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol 187:816&#8211;821. 10.1016/j.juro.2011.10.173<pub-id pub-id-type="pmid">22248514</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.juro.2011.10.173</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zargar</surname><given-names>H</given-names></name><name name-style="western"><surname>Bhayani</surname><given-names>S</given-names></name><name name-style="western"><surname>Allaf</surname><given-names>ME</given-names></name><name name-style="western"><surname>Stifelman</surname><given-names>M</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>C</given-names></name><name name-style="western"><surname>Larson</surname><given-names>J</given-names></name><name name-style="western"><surname>Ball</surname><given-names>MW</given-names></name><name name-style="western"><surname>Marshall</surname><given-names>S</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>R</given-names></name><name name-style="western"><surname>Fergany</surname><given-names>A</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>S</given-names></name><name name-style="western"><surname>Kaouk</surname><given-names>J</given-names></name></person-group><article-title>Comparison of perioperative outcomes of robot-assisted partial nephrectomy and open partial nephrectomy in patients with a solitary kidney</article-title><source>J Endourol</source><year>2014</year><volume>28</volume><fpage>1224</fpage><lpage>1230</lpage><pub-id pub-id-type="doi">10.1089/end.2014.0297</pub-id><pub-id pub-id-type="pmid">24959704</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Zargar H, Bhayani S, Allaf ME, Stifelman M, Rogers C, Larson J, Ball MW, Marshall S, Kumar R, Fergany A, Campbell S, Kaouk J (2014) Comparison of perioperative outcomes of robot-assisted partial nephrectomy and open partial nephrectomy in patients with a solitary kidney. J Endourol 28:1224&#8211;1230. 10.1089/end.2014.0297<pub-id pub-id-type="pmid">24959704</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/end.2014.0297</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zargar</surname><given-names>H</given-names></name><name name-style="western"><surname>Isac</surname><given-names>W</given-names></name><name name-style="western"><surname>Autorino</surname><given-names>R</given-names></name><name name-style="western"><surname>Khalifeh</surname><given-names>A</given-names></name><name name-style="western"><surname>Nemer</surname><given-names>O</given-names></name><name name-style="western"><surname>Akca</surname><given-names>O</given-names></name><name name-style="western"><surname>Laydner</surname><given-names>H</given-names></name><name name-style="western"><surname>Brandao</surname><given-names>LF</given-names></name><name name-style="western"><surname>Stein</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Kaouk</surname><given-names>JH</given-names></name></person-group><article-title>Robot-assisted laparoscopic partial nephrectomy in patients with previous abdominal surgery: single center experience</article-title><source>Int J Med Robot</source><year>2015</year><volume>11</volume><fpage>389</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1002/rcs.1633</pub-id><pub-id pub-id-type="pmid">25600756</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Zargar H, Isac W, Autorino R, Khalifeh A, Nemer O, Akca O, Laydner H, Brandao LF, Stein RJ, Kaouk JH (2015) Robot-assisted laparoscopic partial nephrectomy in patients with previous abdominal surgery: single center experience. Int J Med Robot 11:389&#8211;394. 10.1002/rcs.1633<pub-id pub-id-type="pmid">25600756</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/rcs.1633</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gill</surname><given-names>IS</given-names></name><name name-style="western"><surname>Kavoussi</surname><given-names>LR</given-names></name><name name-style="western"><surname>Lane</surname><given-names>BR</given-names></name><name name-style="western"><surname>Blute</surname><given-names>ML</given-names></name><name name-style="western"><surname>Babineau</surname><given-names>D</given-names></name><name name-style="western"><surname>Colombo</surname><given-names>JR</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Frank</surname><given-names>I</given-names></name><name name-style="western"><surname>Permpongkosol</surname><given-names>S</given-names></name><name name-style="western"><surname>Weight</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Kaouk</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kattan</surname><given-names>MW</given-names></name><name name-style="western"><surname>Novick</surname><given-names>AC</given-names></name></person-group><article-title>Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors</article-title><source>J Urol</source><year>2007</year><volume>178</volume><fpage>41</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2007.03.038</pub-id><pub-id pub-id-type="pmid">17574056</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, Frank I, Permpongkosol S, Weight CJ, Kaouk JH, Kattan MW, Novick AC (2007) Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 178:41&#8211;46. 10.1016/j.juro.2007.03.038<pub-id pub-id-type="pmid">17574056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.juro.2007.03.038</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chavali</surname><given-names>JSS</given-names></name><name name-style="western"><surname>Bertolo</surname><given-names>R</given-names></name><name name-style="western"><surname>Kara</surname><given-names>O</given-names></name><name name-style="western"><surname>Garisto</surname><given-names>J</given-names></name><name name-style="western"><surname>Mouracade</surname><given-names>P</given-names></name><name name-style="western"><surname>Nelson</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Dagenais</surname><given-names>J</given-names></name><name name-style="western"><surname>Kaouk</surname><given-names>JH</given-names></name></person-group><article-title>Renal arterial pseudoaneurysm after partial nephrectomy: literature review and single-center analysis of predictive factors and renal functional outcomes</article-title><source>J Laparoendosc Adv Surg Tech A</source><year>2019</year><volume>29</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1089/lap.2018.0364</pub-id><pub-id pub-id-type="pmid">30300074</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Chavali JSS, Bertolo R, Kara O, Garisto J, Mouracade P, Nelson RJ, Dagenais J, Kaouk JH (2019) Renal arterial pseudoaneurysm after partial nephrectomy: literature review and single-center analysis of predictive factors and renal functional outcomes. J Laparoendosc Adv Surg Tech A 29:45&#8211;50. 10.1089/lap.2018.0364<pub-id pub-id-type="pmid">30300074</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/lap.2018.0364</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>S</given-names></name><name name-style="western"><surname>Nyirenda</surname><given-names>T</given-names></name><name name-style="western"><surname>Yates</surname><given-names>J</given-names></name><name name-style="western"><surname>Munver</surname><given-names>R</given-names></name></person-group><article-title>Incidence of renal artery pseudoaneurysm following open and minimally invasive partial nephrectomy: a systematic review and comparative analysis</article-title><source>J Urol</source><year>2013</year><volume>189</volume><fpage>1643</fpage><lpage>1648</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2012.11.170</pub-id><pub-id pub-id-type="pmid">23219544</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Jain S, Nyirenda T, Yates J, Munver R (2013) Incidence of renal artery pseudoaneurysm following open and minimally invasive partial nephrectomy: a systematic review and comparative analysis. J Urol 189:1643&#8211;1648. 10.1016/j.juro.2012.11.170<pub-id pub-id-type="pmid">23219544</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.juro.2012.11.170</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sam</surname><given-names>K</given-names></name><name name-style="western"><surname>Gahide</surname><given-names>G</given-names></name><name name-style="western"><surname>Soulez</surname><given-names>G</given-names></name><name name-style="western"><surname>Giroux</surname><given-names>MF</given-names></name><name name-style="western"><surname>Oliva</surname><given-names>VL</given-names></name><name name-style="western"><surname>Perreault</surname><given-names>P</given-names></name><name name-style="western"><surname>Bouchard</surname><given-names>L</given-names></name><name name-style="western"><surname>Gilbert</surname><given-names>P</given-names></name><name name-style="western"><surname>Therasse</surname><given-names>E</given-names></name></person-group><article-title>Percutaneous embolization of iatrogenic arterial kidney injuries: safety, efficacy, and impact on blood pressure and renal function</article-title><source>J Vasc Interv Radiol</source><year>2011</year><volume>22</volume><fpage>1563</fpage><lpage>1568</lpage><pub-id pub-id-type="doi">10.1016/j.jvir.2011.06.020</pub-id><pub-id pub-id-type="pmid">21840226</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Sam K, Gahide G, Soulez G, Giroux MF, Oliva VL, Perreault P, Bouchard L, Gilbert P, Therasse E (2011) Percutaneous embolization of iatrogenic arterial kidney injuries: safety, efficacy, and impact on blood pressure and renal function. J Vasc Interv Radiol 22:1563&#8211;1568. 10.1016/j.jvir.2011.06.020<pub-id pub-id-type="pmid">21840226</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jvir.2011.06.020</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghoneim</surname><given-names>TP</given-names></name><name name-style="western"><surname>Thornton</surname><given-names>RH</given-names></name><name name-style="western"><surname>Solomon</surname><given-names>SB</given-names></name><name name-style="western"><surname>Adamy</surname><given-names>A</given-names></name><name name-style="western"><surname>Favaretto</surname><given-names>RL</given-names></name><name name-style="western"><surname>Russo</surname><given-names>P</given-names></name></person-group><article-title>Selective arterial embolization for pseudoaneurysms and arteriovenous fistula of renal artery branches following partial nephrectomy</article-title><source>J Urol</source><year>2011</year><volume>185</volume><fpage>2061</fpage><lpage>2065</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2011.02.049</pub-id><pub-id pub-id-type="pmid">21496835</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Ghoneim TP, Thornton RH, Solomon SB, Adamy A, Favaretto RL, Russo P (2011) Selective arterial embolization for pseudoaneurysms and arteriovenous fistula of renal artery branches following partial nephrectomy. J Urol 185:2061&#8211;2065. 10.1016/j.juro.2011.02.049<pub-id pub-id-type="pmid">21496835</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.juro.2011.02.049</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kutikov</surname><given-names>A</given-names></name><name name-style="western"><surname>Uzzo</surname><given-names>RG</given-names></name></person-group><article-title>The R.E.N.A.L. Nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth</article-title><source>J Urol</source><year>2009</year><volume>182</volume><fpage>844</fpage><lpage>853</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2009.05.035</pub-id><pub-id pub-id-type="pmid">19616235</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Kutikov A, Uzzo RG (2009) The R.E.N.A.L. Nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182:844&#8211;853. 10.1016/j.juro.2009.05.035<pub-id pub-id-type="pmid">19616235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.juro.2009.05.035</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ficarra</surname><given-names>V</given-names></name><name name-style="western"><surname>Novara</surname><given-names>G</given-names></name><name name-style="western"><surname>Secco</surname><given-names>S</given-names></name><name name-style="western"><surname>Macchi</surname><given-names>V</given-names></name><name name-style="western"><surname>Porzionato</surname><given-names>A</given-names></name><name name-style="western"><surname>De Caro</surname><given-names>R</given-names></name><name name-style="western"><surname>Artibani</surname><given-names>W</given-names></name></person-group><article-title>Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery</article-title><source>Eur Urol</source><year>2009</year><volume>56</volume><fpage>786</fpage><lpage>793</lpage><pub-id pub-id-type="doi">10.1016/j.eururo.2009.07.040</pub-id><pub-id pub-id-type="pmid">19665284</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Ficarra V, Novara G, Secco S, Macchi V, Porzionato A, De Caro R, Artibani W (2009) Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 56:786&#8211;793. 10.1016/j.eururo.2009.07.040<pub-id pub-id-type="pmid">19665284</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.eururo.2009.07.040</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jung</surname><given-names>S</given-names></name><name name-style="western"><surname>Min</surname><given-names>GE</given-names></name><name name-style="western"><surname>Chung</surname><given-names>BI</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>SH</given-names></name></person-group><article-title>Risk factors for postoperative hemorrhage after partial nephrectomy</article-title><source>Korean J Urol</source><year>2014</year><volume>55</volume><fpage>17</fpage><pub-id pub-id-type="doi">10.4111/kju.2014.55.1.17</pub-id><pub-id pub-id-type="pmid">24466392</pub-id><pub-id pub-id-type="pmcid">PMC3897624</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Jung S, Min GE, Chung BI, Jeon SH (2014) Risk factors for postoperative hemorrhage after partial nephrectomy. Korean J Urol 55:17. 10.4111/kju.2014.55.1.17<pub-id pub-id-type="pmid">24466392</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4111/kju.2014.55.1.17</pub-id><pub-id pub-id-type="pmcid">PMC3897624</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>DY</given-names></name><name name-style="western"><surname>Lee</surname><given-names>JS</given-names></name><name name-style="western"><surname>Ahmad</surname><given-names>A</given-names></name><name name-style="western"><surname>Chang</surname><given-names>KD</given-names></name><name name-style="western"><surname>Ham</surname><given-names>WS</given-names></name><name name-style="western"><surname>Han</surname><given-names>WK</given-names></name><name name-style="western"><surname>Hong</surname><given-names>CH</given-names></name><name name-style="western"><surname>Choi</surname><given-names>YD</given-names></name><name name-style="western"><surname>Rha</surname><given-names>KH</given-names></name></person-group><article-title>Lessons learned from clinical outcome and tumor features of patients underwent selective artery embolization due to postoperative bleeding following 2076 partial nephrectomies: propensity scoring matched study</article-title><source>World J Urol</source><year>2020</year><volume>38</volume><fpage>1235</fpage><lpage>1242</lpage><pub-id pub-id-type="doi">10.1007/s00345-019-02883-8</pub-id><pub-id pub-id-type="pmid">31346763</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Chung DY, Lee JS, Ahmad A, Chang KD, Ham WS, Han WK, Hong CH, Choi YD, Rha KH (2020) Lessons learned from clinical outcome and tumor features of patients underwent selective artery embolization due to postoperative bleeding following 2076 partial nephrectomies: propensity scoring matched study. World J Urol 38:1235&#8211;1242. 10.1007/s00345-019-02883-8<pub-id pub-id-type="pmid">31346763</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00345-019-02883-8</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Omae</surname><given-names>K</given-names></name><name name-style="western"><surname>Kondo</surname><given-names>T</given-names></name><name name-style="western"><surname>Takagi</surname><given-names>T</given-names></name><name name-style="western"><surname>Morita</surname><given-names>S</given-names></name><name name-style="western"><surname>Hashimoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>H</given-names></name><name name-style="western"><surname>Iizuka</surname><given-names>J</given-names></name><name name-style="western"><surname>Nozaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Yoshida</surname><given-names>K</given-names></name><name name-style="western"><surname>Tanabe</surname><given-names>K</given-names></name></person-group><article-title>Renal sinus exposure as an independent factor predicting asymptomatic unruptured pseudoaneurysm formation detected in the early postoperative period after minimally invasive partial nephrectomy</article-title><source>Int J Urol</source><year>2015</year><volume>22</volume><fpage>356</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1111/iju.12696</pub-id><pub-id pub-id-type="pmid">25581594</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Omae K, Kondo T, Takagi T, Morita S, Hashimoto Y, Kobayashi H, Iizuka J, Nozaki T, Yoshida K, Tanabe K (2015) Renal sinus exposure as an independent factor predicting asymptomatic unruptured pseudoaneurysm formation detected in the early postoperative period after minimally invasive partial nephrectomy. Int J Urol 22:356&#8211;361. 10.1111/iju.12696<pub-id pub-id-type="pmid">25581594</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/iju.12696</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hyams</surname><given-names>ES</given-names></name><name name-style="western"><surname>Pierorazio</surname><given-names>P</given-names></name><name name-style="western"><surname>Proteek</surname><given-names>O</given-names></name><name name-style="western"><surname>Sukumar</surname><given-names>S</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>AA</given-names></name><name name-style="western"><surname>Mechaber</surname><given-names>JL</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>C</given-names></name><name name-style="western"><surname>Kavoussi</surname><given-names>L</given-names></name><name name-style="western"><surname>Allaf</surname><given-names>M</given-names></name></person-group><article-title>Iatrogenic vascular lesions after minimally invasive partial nephrectomy: a multi-institutional study of clinical and renal functional outcomes</article-title><source>Urology</source><year>2011</year><volume>78</volume><fpage>820</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1016/j.urology.2011.04.063</pub-id><pub-id pub-id-type="pmid">21813164</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Hyams ES, Pierorazio P, Proteek O, Sukumar S, Wagner AA, Mechaber JL, Rogers C, Kavoussi L, Allaf M (2011) Iatrogenic vascular lesions after minimally invasive partial nephrectomy: a multi-institutional study of clinical and renal functional outcomes. Urology 78:820&#8211;826. 10.1016/j.urology.2011.04.063<pub-id pub-id-type="pmid">21813164</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.urology.2011.04.063</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>D</given-names></name><name name-style="western"><surname>Gill</surname><given-names>IS</given-names></name></person-group><article-title>Renal artery pseudoaneurysm following laparoscopic partial nephrectomy</article-title><source>J Urol</source><year>2005</year><volume>174</volume><fpage>2256</fpage><lpage>2259</lpage><pub-id pub-id-type="doi">10.1097/01.ju.0000181827.49239.8e</pub-id><pub-id pub-id-type="pmid">16280793</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Singh D, Gill IS (2005) Renal artery pseudoaneurysm following laparoscopic partial nephrectomy. J Urol 174:2256&#8211;2259. 10.1097/01.ju.0000181827.49239.8e<pub-id pub-id-type="pmid">16280793</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.ju.0000181827.49239.8e</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Netsch</surname><given-names>C</given-names></name><name name-style="western"><surname>Br&#252;ning</surname><given-names>R</given-names></name><name name-style="western"><surname>Bach</surname><given-names>T</given-names></name><name name-style="western"><surname>Gross</surname><given-names>AJ</given-names></name></person-group><article-title>Management of renal artery pseudoaneurysm after partial nephrectomy</article-title><source>World J Urol</source><year>2010</year><volume>28</volume><fpage>519</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1007/s00345-010-0572-0</pub-id><pub-id pub-id-type="pmid">20563584</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Netsch C, Br&#252;ning R, Bach T, Gross AJ (2010) Management of renal artery pseudoaneurysm after partial nephrectomy. World J Urol 28:519&#8211;524. 10.1007/s00345-010-0572-0<pub-id pub-id-type="pmid">20563584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00345-010-0572-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nadu</surname><given-names>A</given-names></name><name name-style="western"><surname>Kleinmann</surname><given-names>N</given-names></name><name name-style="western"><surname>Laufer</surname><given-names>M</given-names></name><name name-style="western"><surname>Dotan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Winkler</surname><given-names>H</given-names></name><name name-style="western"><surname>Ramon</surname><given-names>J</given-names></name></person-group><article-title>Laparoscopic partial nephrectomy for central tumors: analysis of perioperative outcomes and complications</article-title><source>J Urol</source><year>2009</year><volume>181</volume><fpage>42</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.juro.2008.09.014</pub-id><pub-id pub-id-type="pmid">19012908</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Nadu A, Kleinmann N, Laufer M, Dotan Z, Winkler H, Ramon J (2009) Laparoscopic partial nephrectomy for central tumors: analysis of perioperative outcomes and complications. J Urol 181:42&#8211;47. 10.1016/j.juro.2008.09.014<pub-id pub-id-type="pmid">19012908</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.juro.2008.09.014</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>M</given-names></name><name name-style="western"><surname>Wu</surname><given-names>P</given-names></name><name name-style="western"><surname>Li</surname><given-names>T</given-names></name><name name-style="western"><surname>Ning</surname><given-names>X</given-names></name><name name-style="western"><surname>Peng</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>J</given-names></name><name name-style="western"><surname>Qi</surname><given-names>N</given-names></name><name name-style="western"><surname>Gong</surname><given-names>K</given-names></name></person-group><article-title>Renal arterial pseudoaneurysm and renal arteriovenous fistula following partial nephrectomy</article-title><source>Urol Int</source><year>2018</year><volume>100</volume><fpage>368</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1159/000443700</pub-id><pub-id pub-id-type="pmid">26795724</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Chen J, Yang M, Wu P, Li T, Ning X, Peng S, Wang J, Qi N, Gong K (2018) Renal arterial pseudoaneurysm and renal arteriovenous fistula following partial nephrectomy. Urol Int 100:368&#8211;374. 10.1159/000443700<pub-id pub-id-type="pmid">26795724</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000443700</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sempels</surname><given-names>M</given-names></name><name name-style="western"><surname>Ben Chehida</surname><given-names>MA</given-names></name><name name-style="western"><surname>Meunier</surname><given-names>P</given-names></name><name name-style="western"><surname>Waltregny</surname><given-names>D</given-names></name></person-group><article-title>Open and laparoscopic partial nephrectomy: comparison and validation of preoperative scoring systems, including padua, RENAL, ABC nephrometric scores and perinephric fat evaluation with Mayo adhesive probability score</article-title><source>Res Rep Urol</source><year>2021</year><volume>13</volume><fpage>509</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.2147/rru.s293864</pub-id><pub-id pub-id-type="pmid">34322455</pub-id><pub-id pub-id-type="pmcid">PMC8302811</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Sempels M, Ben Chehida MA, Meunier P, Waltregny D (2021) Open and laparoscopic partial nephrectomy: comparison and validation of preoperative scoring systems, including padua, RENAL, ABC nephrometric scores and perinephric fat evaluation with Mayo adhesive probability score. Res Rep Urol 13:509&#8211;517. 10.2147/rru.s293864<pub-id pub-id-type="pmid">34322455</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/RRU.S293864</pub-id><pub-id pub-id-type="pmcid">PMC8302811</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>